MHRA aprueba la vacuna COVID-19 de ARNm de Moderna

Medicines and Healthcare products Regulatory Agency (MHRA), the regulator of all medicines and medical devices in the UK has approved Moderna's COVID-19 vaccine after meeting the required safety, quality and effectiveness standards for use in the UK ⁽¹⁾.  

This is the third COVID-19 vaccine to be approved in the UK after Pfizer/BioNTech’s ARNm vaccine BNT162b2 and Oxford/AstraZeneca’s ChAdOx1 nCoV-2019.  

Al igual que BNT162b2 de Pfizer / BioNTech, este vacuna también es un vacuna de ARNm and works on the same principle of injecting viral ARNm in to the cells ⁽²⁾.  

***

Fuentes:  

1. MHRA 2021. Press release – moderno vaccine becomes third COVID-19 vaccine approved by UK regulator. Published 8 January 2021. Available on https://www.gov.uk/government/news/moderna-vaccine-becomes-third-covid-19-vaccine-approved-by-uk-regulator Consultado el 08 de enero de 2021.  

2. Prasad U., 2020. COVID-19 ARNm Vaccine: A Milestone in Science and a Game Changer in Medicine. Scientific European. Posted online on 29 December 2020. Available online on https://www.scientificeuropean.co.uk/medicine/covid-19-mrna-vaccine-a-milestone-in-science-and-a-game-changer-in-medicine/ Consultado el 08 de enero de 2021.  

***